SG Americas Securities’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43K | Sell |
12,648
-13,626
| -52% | -$46.3K | ﹤0.01% | 2437 |
|
|
2025
Q1 | $105K | Buy |
+26,274
| New | +$105K | ﹤0.01% | 2671 |
|
|
2024
Q3 | – | Sell |
-32,333
| Closed | -$180K | – | 2996 |
|
|
2024
Q2 | $180K | Buy |
+32,333
| New | +$180K | ﹤0.01% | 1961 |
|
|
2023
Q4 | – | Sell |
-188,813
| Closed | -$1.04M | – | 2802 |
|
|
2023
Q3 | $1.04M | Buy |
188,813
+48,816
| +35% | +$269K | 0.01% | 1141 |
|
|
2023
Q2 | $1.2M | Buy |
139,997
+56,086
| +67% | +$479K | 0.01% | 875 |
|
|
2023
Q1 | $771K | Sell |
83,911
-44,843
| -35% | -$412K | 0.01% | 1244 |
|
|
2022
Q4 | $1.32M | Buy |
128,754
+108,209
| +527% | +$1.11M | 0.02% | 682 |
|
|
2022
Q3 | $302K | Sell |
20,545
-10,245
| -33% | -$151K | ﹤0.01% | 1769 |
|
|
2022
Q2 | $330K | Buy |
+30,790
| New | +$330K | ﹤0.01% | 2108 |
|
|
2021
Q4 | – | Sell |
-6,890
| Closed | -$148K | – | 3028 |
|
|
2021
Q3 | $148K | Buy |
+6,890
| New | +$148K | ﹤0.01% | 3174 |
|